The return of Adam Bosworth
The former head of Google’s health initiative, who resigned abruptly while on vacation last month, has finally resurfaced, according to his blog. It’s not exactly the first sighting of Bosworth since his departure from Google — I was told he turned up briefly at the Health 2.0 conference last month, although he apparently wasn’t saying much about what had happened — but it’s the most detailed update most of us have seen since he vanished.
Which… Continue Reading
Roundup: Thailand vs. Big Pharma, kids with heart disease, biomedical research funding, and more
Arm wrestling over drug patents – Three months ago, the military government running Thailand informed Abbott Laboratories that it intended to break the company’s patents on several expensive drugs, including the HIV protease inhibitor Kaletra, thus allowing the manufacture or import of cheaper knockoffs. Abbott responded by dropping its plans to bring newer drugs, including a heat-resistant version of Kaletra, to Thailand, and the pharma and the junta have been locked in a standoff ever since…. Continue Reading